Gossamer Bio, Inc. — Director's Dealing 2023

Jun 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2023-06-08

Reporting Person: Daniel Thomas O (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-08	Stock Option (Right to Buy)	$1.26	A	35000	Acquired	2033-06-07	Common Stock (35000.0)	Direct

Footnotes

F1: Award made pursuant to Non-Employee Director Compensation Program.

F2: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.